Investment will accelerate Scenic Biotech’s transition into a development stage company, advancing its in-house pipeline and supporting the creation of new programs based on its Cell-Seq genetic modifier target discovery platform including new industry collaborations.
eHealth Technologies Innovates to Advance Patient Access to Life-Saving Medical Treatment
Fri Mar 11 , 2022